Select Publications

Book Chapters

Jun M; Perkovic V, 2015, 'Fibrates: risk-benefits and role in treating dyslipidemias', in Dyslipidemias Pathophysiology, Evaluation and Management, Humana Press

Jun M; Perkovic V; Cass A, 2011, 'Intensive glycemic control and renal outcome', in Diabetes and the Kidney, Karger Medical and Scientific Publishers

Journal articles

Maeda T; Woodward M; Jun M; Sakamoto Y; Chen X; Matsushita K; Mancia G; Arima H; Anderson CS; Chalmers J; Harris K, 2024, 'Risk of recurrent stroke and dementia following acute stroke by changes in kidney function: results from the Perindopril Protection Against Recurrent Stroke Study', Journal of Hypertension, 42, pp. 1313 - 1321, http://dx.doi.org/10.1097/HJH.0000000000003711

Scholes-Robertson N; Guha C; Gutman T; Howell M; Yip A; Cashmore B; Roberts I; Lopez-Vargas P; Wong G; MacGinley R; Synnot A; Craig JC; Jauré A; Krishnasamy R; Tunnicliffe DJ; Lee V; Boag J; Coolican H; Cullen V; Fortnum D; Hassan H; Jun M; Lambert K; Light C; Nguyen T; Palmer S; Scuderi C; See E; Viecelli A; Walker R, 2024, 'Consumer involvement in the development and dissemination of chronic kidney disease guidelines: a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines', Journal of Clinical Epidemiology, 170, http://dx.doi.org/10.1016/j.jclinepi.2024.111330

Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV, 2024, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, 83, pp. 350 - 359.e1, http://dx.doi.org/10.1053/j.ajkd.2023.07.023

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Ha J; Hiremath S; Jun M; Palmer S; Wheeler D; Coyne D; Perkovic V; Badve S, 2024, 'WCN24-2313 LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS', Kidney International Reports, 9, pp. S562 - S563, http://dx.doi.org/10.1016/j.ekir.2024.02.1183

Colombijn JMT; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RWM, 2023, 'Antioxidants for adults with chronic kidney disease', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD008176.pub3

Young TK; Hockham C; Sukkar L; Kang A; Jun M; Foote C; Baker J; Rogers K; Zoungas S; Cass A; Sullivan D; Jardine MJ, 2023, 'Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study', Endocrine and Metabolic Science, 12, http://dx.doi.org/10.1016/j.endmts.2023.100135

Jun M; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Ha J; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; Mcarthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M, 2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069

Pettigrew S; Santos JA; Li Y; Jun M; Anderson C; Jones A, 2023, 'Short report: Factors contributing to young people's susceptibility to e-cigarettes in four countries', Drug and Alcohol Dependence, 250, http://dx.doi.org/10.1016/j.drugalcdep.2023.109944

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Agarwal R; Bakris G; Chang TI; Heerspink HJL; Jardine MJ; Mahaffey KW; Neal B; Pollock C; Jun M; Rodgers A; Perkovic V; Neuen BL, 2023, 'Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials', Journal of the American Heart Association, 12, pp. e028516, http://dx.doi.org/10.1161/JAHA.122.028516

Ha JT; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Lam D; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M, 2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675

Harris K; Muntner P; Woodward M; Jun M; Oshima M; Gong J; Harrap S; Menard J; Chalmers J, 2023, 'Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes', Journal of Human Hypertension, 37, pp. 181 - 188, http://dx.doi.org/10.1038/s41371-022-00661-5

Pettigrew S; Alvin Santos J; Miller M; Sudhir Raj T; Jun M; Morelli G; Jones A, 2023, 'E-cigarettes: A continuing public health challenge in India despite comprehensive bans', Preventive Medicine Reports, 31, http://dx.doi.org/10.1016/j.pmedr.2022.102108

Feng Y; Wang AY; Jun M; Pu L; Weisbord SD; Bellomo R; Hong D; Gallagher M, 2023, 'Characterization of Risk Prediction Models for Acute Kidney Injury A Systematic Review and Meta-analysis', JAMA Network Open, 6, http://dx.doi.org/10.1001/jamanetworkopen.2023.13359

Talbot B; Cass A; Walker R; Hooi L; Jardine M; Jun M; Rogers K; Sukkar L; Smyth B; Gallagher M, 2023, 'Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection-extended review', Nephrology, 28, pp. 36 - 43, http://dx.doi.org/10.1111/nep.14127

Ha J; Hiremath S; Jun M; Palmer S; Wheeler DC; Coyne DW; Perkovic V; Badve S, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', Journal of the American Society of Nephrology, 34, pp. 367 - 367, http://dx.doi.org/10.1681/asn.20233411s1367a

Jun M; Wick J; Neuen BL; Kotwal SS; Badve S; Chalmers JP; Jardine M; Perkovic V; Gallagher MP; Ronksley PE, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Journal of the American Society of Nephrology, 34, pp. 373 - 373, http://dx.doi.org/10.1681/asn.20233411s1373a

KIM D; Lee J; Toyama T; Liyanage T; Woodward M; Matsushita K; Hooi LS; Lin MY; Iseki K; Jha V; Wong MG; Jun M, 2023, 'WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA', Kidney International Reports, 8, pp. S135 - S136, http://dx.doi.org/10.1016/j.ekir.2023.02.309

Pettigrew S; Miller M; Santos JA; Brown K; Morelli G; Sudhir T; Jun M; Jones A, 2022, 'Young people's support for various forms of e-cigarette regulation in Australia and the UK', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103858

Pettigrew S; Miller M; Kannan A; Raj TS; Jun M; Jones A, 2022, 'School staff perceptions of the nature and consequences of students’ use of e-cigarettes', Australian and New Zealand Journal of Public Health, 46, pp. 676 - 681, http://dx.doi.org/10.1111/1753-6405.13281

Lambert K; Bahceci S; Harrison H; Chan M; Scholes-Robertson N; Johnson DW; Yip A; Viecelli AK; Krishnasamy R; Boag J; Coolican H; Craig J; Jun M; Lee V; Nguyen T; Scuderi C; See E; Walker R; Fortnum D; Cullen V; Howell M; Guha C; Tunnicliffe D; Johnston B, 2022, 'Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease', Nephrology, 27, pp. 537 - 540, http://dx.doi.org/10.1111/nep.14025

Hockham C; Bao L; Tiku A; Badve SV; Bello AK; Jardine MJ; Jha V; Toyama T; Woodward M; Jun M, 2022, 'Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis', Clinical Kidney Journal, 15, pp. 1144 - 1151, http://dx.doi.org/10.1093/ckj/sfac030

Kang A; Sukkar L; Hockham C; Jun M; Young T; Scaria A; Foote C; Neuen BL; Cass A; Pollock C; Comino E; Lung T; Pecoits-Filho R; Rogers K; Jardine MJ; Chow C; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Ssullivan D; Wong G; Zoungas S; Wilson R, 2022, 'Risk factors for incident kidney disease in older adults: an Australian prospective population-based study', Internal Medicine Journal, 52, pp. 808 - 817, http://dx.doi.org/10.1111/imj.15074

Campain A; Hockham C; Sukkar L; Rogers K; Chow CK; Lung T; Jun M; Pollock C; Cass A; Sullivan D; Comino E; Peiris D; Jardine M, 2022, 'Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction', Frontiers in Pharmacology, 13, http://dx.doi.org/10.3389/fphar.2022.834898

Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395

Chidwick K; Myton R; Rodgers A; Jun M; Dartnell J; Balcomb A; Dore G, 2022, 'A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)', Journal of Viral Hepatitis, 29, pp. 135 - 146, http://dx.doi.org/10.1111/jvh.13629

Liyanage T; Toyama T; Hockham C; Ninomiya T; Perkovic V; Woodward M; Fukagawa M; Matsushita K; Praditpornsilpa K; Hooi LS; Iseki K; Lin MY; Stirnadel-Farrant HA; Jha V; Jun M, 2022, 'Prevalence of chronic kidney disease in Asia: A systematic review and analysis', BMJ Global Health, 7, pp. e007525, http://dx.doi.org/10.1136/bmjgh-2021-007525

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Heerspink HJ; Neal B; Jun M; Rodgers A; Perkovic V; Neuen B, 2022, 'Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', Hypertension, 79, http://dx.doi.org/10.1161/hyp.79.suppl_1.p201

Ha J; Freedman B; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve S, 2022, 'Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 33, pp. 297 - 298, http://dx.doi.org/10.1681/asn.20223311s1297c

Harel Z; McArthur E; Jeyakumar N; Sood MM; Garg AX; Silver SA; Dorian P; Blum D; Beaubien-Souligny W; Yan AT; Badve SV; Smyth B; Jun M; Jandoc R; Kitchlu A; Wald R, 2021, 'The risk of acute kidney injury with oral anticoagulants in elderly adults with atrial fibrillation', Clinical Journal of the American Society of Nephrology, 16, pp. 1470 - 1479, http://dx.doi.org/10.2215/CJN.05920421

Pettigrew S; Jun M; Roberts I; Nallaiah K; Rodgers A, 2021, 'The Potential Effectiveness of COVID-Related Smoking Cessation Messages in Three Countries', Nicotine and Tobacco Research, 23, pp. 1254 - 1258, http://dx.doi.org/10.1093/ntr/ntab023

Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Matteau A; Paterson JM; Quail J; Renoux C, 2021, 'Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis', British Journal of Clinical Pharmacology, 87, pp. 2589 - 2601, http://dx.doi.org/10.1111/bcp.14669

Jun M; Harris K; Heerspink HJL; Badve SV; Jardine MJ; Harrap S; Hamet P; Marre M; Poulter N; Kotwal S; Gallagher M; Perkovic V; Chalmers J; Woodward M, 2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351

Nataatmadja M; Krishnasamy R; Zuo L; Hong D; Smyth B; Jun M; de Zoysa JR; Howard K; Wang J; Lu C; Liu Z; Chan CT; Cass A; Perkovic V; Jardine M; Gray NA, 2021, 'Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis', Kidney International Reports, 6, pp. 1058 - 1065, http://dx.doi.org/10.1016/j.ekir.2021.01.020

O'Hara DV; Parkhill TR; Badve SV; Jun M; Jardine MJ; Perkovic V, 2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281

Palagyi A; Balane C; Shanthosh J; Jun M; Bhoo-Pathy N; Gadsden T; Canfell K; Jan S, 2021, 'Treatment abandonment in children with cancer: Does a sex difference exist? A systematic review and meta-analysis of evidence from low- and middle-income countries', International Journal of Cancer, 148, pp. 895 - 904, http://dx.doi.org/10.1002/ijc.33279

Oshima M; Hara A; Toyama T; Jun M; Pollock C; Jardine M; Harrap S; Poulter N; Cooper ME; Woodward M; Chalmers J; Perkovic V; Wong MG; Wada T, 2021, 'Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor', Kidney International Reports, 6, pp. 284 - 295, http://dx.doi.org/10.1016/j.ekir.2020.10.039

Neuen BL; Arnott C; Perkovic V; Figtree G; de Zeeuw D; Fulcher G; Jun M; Jardine MJ; Zoungas S; Pollock C; Mahaffey KW; Neal B; Heerspink HJL, 2021, 'Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes', Diabetes, Obesity and Metabolism, 23, pp. 382 - 390, http://dx.doi.org/10.1111/dom.14226

Riaz P; Caskey F; McIsaac M; Davids R; Htay H; Jha V; Jindal K; Jun M; Khan M; Levin A; Lunney M; Okpechi I; Pecoits-Filho R; Osman MA; Vachharajani T; Ye F; Harris D; Tonelli M; Johnson D; Bello A, 2021, 'Workforce capacity for the care of patients with kidney failure across world countries and regions', BMJ Global Health, 6, http://dx.doi.org/10.1136/bmjgh-2020-004014

Talbot B; Lin R; Li Q; Jun M; Kotwal S; Sen S; Gallagher M, 2021, 'The Impact of Clinical Presentation on Survival in Patients Requiring Hemodialysis Catheters for Acute and Unplanned Dialysis: A Prospective Observational Study', Canadian Journal of Kidney Health and Disease, 8, http://dx.doi.org/10.1177/20543581211009986

Jun M; Gallagher MP, 2021, 'The Comparative Effectiveness and Safety of Direct Oral Anticoagulant (DOAC) and Warfarin Initiation in Adults with Atrial Fibrillation (AF) by eGFR Category', Journal of the American Society of Nephrology, 32, pp. 37 - 37, http://dx.doi.org/10.1681/asn.20213210s137b

Ha J; Gallagher MP; Jun M, 2021, 'The Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Initiation in Adults with Atrial Fibrillation (AF) by eGFR Category', Journal of the American Society of Nephrology, 32, pp. 728 - 728, http://dx.doi.org/10.1681/asn.20213210s1728c

Kim H; Wang D; Chalmers J; Jun M; Zoungas S; Marre M; Hamet P; Harrap S; Mancia G; Poulter NR; Cooper ME; Woodward M; Selvin E; Rebholz CM, 2020, 'Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial', Journal of Diabetes, 12, pp. 929 - 941, http://dx.doi.org/10.1111/1753-0407.13083

Zhang H; Rogers K; Sukkar L; Jun M; Kang A; Young T; Campain A; Cass A; Chow CK; Comino E; Foote C; Gallagher M; Knight J; Liu B; Lung T; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Jardine M; Hockham C, 2020, 'Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data', Journal of Clinical and Translational Endocrinology, 22, pp. 100240, http://dx.doi.org/10.1016/j.jcte.2020.100240

Pettigrew S; Jun M; Roberts I; Bullen C; Nallaiah K; Rodgers A, 2020, 'Preferences for tobacco cessation information and support during Covid-19', Journal of Addiction Medicine, 14, pp. E362 - E365, http://dx.doi.org/10.1097/ADM.0000000000000743

Xie Y; Baker J; Young T; Jun M; Sukkar L; Campain A; Kang A; Cass A; Hu J; Peiris D; Pollock C; Wong G; Zoungas S; Rogers K; Jardine M; Hockham C, 2020, 'Therapy escalation following an elevated hba1c in adults aged 45 years and older living with diabetes in Australia: A real-world observational analysis', Diabetes Care, 43, pp. e185 - e187, http://dx.doi.org/10.2337/dc20-0269

Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A, 2020, 'Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study', CMAJ open, 8, pp. E877 - E886, http://dx.doi.org/10.9778/cmajo.20200055


Back to profile page